- Home
- AGD vs SOPH Comparison
AGD vs SOPH Comparison
Compare AGD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGD
- SOPH
- Stock Information
- Founded
- AGD 2006
- SOPH 2011
- Country
- AGD United Kingdom
- SOPH Switzerland
- Employees
- AGD N/A
- SOPH N/A
- Industry
- AGD Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGD Finance
- SOPH Health Care
- Exchange
- AGD Nasdaq
- SOPH Nasdaq
- Market Cap
- AGD 253.4M
- SOPH 247.0M
- IPO Year
- AGD N/A
- SOPH 2021
- Fundamental
- Price
- AGD $10.51
- SOPH $3.44
- Analyst Decision
- AGD
- SOPH Strong Buy
- Analyst Count
- AGD 0
- SOPH 3
- Target Price
- AGD N/A
- SOPH $7.00
- AVG Volume (30 Days)
- AGD 61.2K
- SOPH 31.4K
- Earning Date
- AGD 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- AGD 8.13%
- SOPH N/A
- EPS Growth
- AGD N/A
- SOPH N/A
- EPS
- AGD N/A
- SOPH N/A
- Revenue
- AGD N/A
- SOPH $64,938,000.00
- Revenue This Year
- AGD N/A
- SOPH $7.70
- Revenue Next Year
- AGD N/A
- SOPH $20.61
- P/E Ratio
- AGD N/A
- SOPH N/A
- Revenue Growth
- AGD N/A
- SOPH 20.14
- 52 Week Low
- AGD $8.20
- SOPH $2.70
- 52 Week High
- AGD $9.78
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- AGD 60.23
- SOPH 42.22
- Support Level
- AGD $10.35
- SOPH $3.03
- Resistance Level
- AGD $10.52
- SOPH $3.49
- Average True Range (ATR)
- AGD 0.08
- SOPH 0.22
- MACD
- AGD -0.00
- SOPH -0.03
- Stochastic Oscillator
- AGD 57.70
- SOPH 32.21
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.